Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

142 results about "Mutation screening" patented technology

Mutation Screening. Mutation Screening is a tool for couples to identify if they are carriers of a heredity disease. Mutation Screening by Sanger Sequencing is most often recommended when the genetic disease has previously been identified or there is a known family history for a particular genetic disease.

Human K-ras (K-rat sarcoma) gene mutation parting type fluorescent quantitation PCR (polymerase chain reaction) detecting reagent kit and detecting method

The invention discloses a human K-ras (K-rat sarcoma) gene mutation parting type fluorescent quantitation PCR (polymerase chain reaction) detecting reagent kit and a detecting method. The detecting reagent kit comprises PCR mixed reaction liquid, a peptide nucleic acid probe, a taqman-MGB (minor groove binder) probe, an inner control forward and reverse primer and probe, an external control forward and reverse primer and probe and a positive reference article, wherein the inner control forward and reverse primer and probe is used for K-ras gene mutation detection, and the external control forward and reverse primer and probe is used for the K-ras gene mutation detection. The PNA (peptide nucleic acid) technology and the taqman-MGB technology are combined, relevant ARMS (amplification refractory mutation system) primers are designed, PNA can be stably combined with wild K-ras genes 12 or 13 codon sequences, only mutation specimens can be amplified, and the K-ras gene mutation can be detected. The method has the advantages that the speed is high, simplicity and convenience are realized, the specificity is good, the sensitivity is high, and the method can be used for the clinical K-ras gene mutation screening.
Owner:武汉海吉力生物科技有限公司

Exome potential pathogenic mutation detection method based on family line

InactiveCN105925685ASolve the problem of mining potential pathogenic variantsImprove heterogeneityMicrobiological testing/measurementBiostatisticsFiltrationSingle mutation
The invention provides an exome potential pathogenic mutation detection method based on a family line. The detection method comprises the following steps: 1) reading a result file of an exome sequencing data processing flow, and conducting function filtering; 2) reading the file obtained in the last step, extracting mutations in all samples, calculating a union set, and then combining all samples, so that a matrix is constituted; 3) extracting mutation information in the matrix obtained in the last step, enumerating and assessing pathogenicity of single mutation and pathogenicity of combined dual-site mutation, so that a potential pathogenic mutation list is obtained; and 4) in accordance with the list obtained in the last step, calculating the appearance situations of sites in various samples and target genes. According to the method disclosed by the invention, data integration and basic filtration are completed by taking an output result of the common exome sequencing processing flow as an input condition; by virtue of a special mutation screening algorithm, a candidate set of the potential pathogenic mutations is provided; and the method focuses on solving a problem on potential pathogenic mutation mining of sequencing data with high heterogeneity, high mutation rate and high noise.
Owner:WANKANGYUAN TIANJIN GENE TECH CO LTD

Strain for generating phospholipase D with high and stable yield by utilizing physical and chemical mutation

The invention relates to a strain for generating phospholipase D with high and stable yield by utilizing physical and chemical mutation, belonging to the technical field of microbial mutation. The strain is characterized in that the phospholipase D is prepared by fermenting streptomyces chromofuscus of high yield phospholipase D, which is obtained by taking the streptomyces chromofuscus as an original strain and sequentially carrying out composite mutation of ultraviolet rays and lithium chloride and composite mutation of atmosphere cold plasmas and the lithium chloride on a monospore bacterial suspension thereof. The invention has the advantages that the streptomyces chromofuscus of the high yield phospholipase D is obtained through mutation screening, thereby providing a high yield strain with higher application value to industrial production of the phospholipase D, laying a good foundation for fermentation culture and application of the phospholipase D, and also providing a good and feasible method for microbial mutation breeding. The invention adopts a mutation and screening method, has the advantages of simple operation, high efficiency and the like, and has a practical value on screening the strain with an industrial application value.
Owner:DALIAN UNIV OF TECH

Selenium-rich yeast, preparing method and application

The invention discloses a selenium-rich yeast, a preparing method and an application. The preparing method includes the following steps that Candida ethanolica is subjected to nitrogen ion-implantation mutagenesis, and is subjected to mutation screening for multiple times, and an Candida ethanolica mutant strain tolerating high-concentration sodium selenite is obtained; a seed culturing solution is prepared, the seed culturing solution is inoculated in a fermentation medium and fermented to the logarithmic phase, the sodium selenite is additionally added into a fermented product, the mixture continues to be fermented and cultured, and a fermented product is collected; fermented liquid is subjected to centrifugal washing and dried, and then a faint-yellow powdery product is obtained. The selenium-rich yeast has a large amount of amino acid and small peptide, and is extremely and easily digested and absorbed by animals, organic selenium in the yeast can be fully absorbed by living bodies along with absorption of the amino acid and the small peptide, and the digestion using rate of the organic selenium is greatly increased. Under the condition of the equivalent additive amount, the selenium-rich yeast has the advantage of being obvious in production performance aspect compared with similar products, or under the condition of the equivalent production performance, the additive amount can be reduced, and the cost is reduced.
Owner:HEFEI INSTITUTES OF PHYSICAL SCIENCE - CHINESE ACAD OF SCI

Congenital adrenal hyperplasia gene screening kit, screening method and application thereof

The present invention discloses a congenital adrenal hyperplasia gene screening kit. The congenital adrenal hyperplasia gene screening kit comprises a PCR amplification primer mixed liquor used for detecting 17 mutation sites including CYP 21A2 gene; an extended primer mixed liquor for the above 17 mutation sites; dNTP; 10*RCR buffer; 25 mM Mg2+ ions; Fast StartTaq enzyme; purification reagent composed of SAP enzyme, Exon I enzyme and a matched buffer; SNaPshot Multiplex mixed liquor; single-site homozygous and heterozygous mutation positive and negative control DNA; and deionized water. According to the technical scheme of the invention, a large number of researches and practices show that, the mutation sites of the congenital adrenal hyperplasia gene in the Chinese population are screened and combined. By utilizing the kit, 17 mutation sites of the specific congenital adrenal hyperplasia gene are simultaneously subjected to multiplex nested PCR amplification, labeling and extending, so that the defects of the existing mutation screening method are overcome. The kit is simple in operation and low in cost. The detection throughput and the accuracy of the detection result are greatly improved compared with the prior art.
Owner:SUZHOU MUNICIPAL HOSPITAL

High throughput mutation screening methods and kits using a universalized approach - differential sequence fill-in (dsf)-enabled sequential adapter ligation and amplification

InactiveUS20090075276A1Facilitate simultaneous detectionProhibiting further ligationMicrobiological testing/measurementFermentationScreening methodSingle strand
This disclosure teaches high throughput mutation screening methods allowing simultaneous analysis of multiple genetic regions of interest and sensitive detection of very low frequency mutation(s) by the use of a universalized approach. Methods comprise treating RNA:DNA heteroduplexes of interest with a ribonuclease, sequence extension by an RNA-primed DNA polymerase, ligation with a blocking adapter, and differential sequence fill-in followed by single-strand-specific nuclease digestion to permit full-length sequence extension and subsequent ligation with a tagged reporter adapter solely in mutants filled in with a complementary deoxyribonucleotide triphosphate. By forming tagged mutant-dual adapter hybrids or mutant-triple adapter hybrids, the detection and/or quantification of mutants may be directed to the commonly shared tag(s) or flanking adapter sequences for signal detection/enhancement or sequence amplification in all different mutants regardless of the source or the number of mutations involved, thereby avoiding the tremendous effort of multiple target-specific sequence amplifications. Methods may be performed wholly or partially in solution, on solid phase media, in large scale, adapted for automated or semi-automated analysis, and any combinations thereof.
Owner:LEE MING SHENG +2

Detection method for mutation screening of disease-causing genes of Parkinson's disease

The invention discloses a detection method for mutation screening of disease-causing genes of Parkinson's disease (PD). The detection method comprises the following steps: (1) adding dd H2O into a synthesized MIPs probe to prepare a probe solution with the concentration of 100mu M; (2) sucking 1mu l of the probe solution in step (1) by utilizing a pipettor; then putting the probe solution into a 1.5ml new EP pipe; sufficiently and uniformly mixing; marking a pipe wall as mixed-MIPs by utilizing a Marker pen; (3) preparing an MIPs probe phosphorylation activation system and carrying out activation on the mixed-MIPs; (4) diluting a mixed-MIPs probe; (5) preparing an MIPs target capturing reaction system; (6) preparing an MIPs enzyme digestion reaction system; (7) carrying out PCR (PolymeraseChain Reaction) amplification reaction; (8) carrying out polyacrylamide gel electrophoresis and magnetic bead purification; (9) carrying out high-throughput sequencing on a mixed library; (10) carrying out Sanger sequencing verification. By adopting the detection method for the mutation screening of the disease-causing genes of the Parkinson's disease, the mutation screening of the 18 PD disease-causing genes of the Parkinson's disease can be finished, and the detection method has important significance on researches of super-early diagnosis and PD pathogenesis of potential PD patients.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products